Trojan Bio
Therapeutic Antibodies for the Treatment of Cancer
StartupTrojan Bio is a Yavne-based startup in the Health Tech & Life Sciences sector, established in 2021. Therapeutic Antibodies for the Treatment of Cancer . Trojan Bio was founded by Anat Burkovitz, Amir Aharoni, Noam Diamant . Key investors include Peregrine Ventures, NFX Capital. The company has 1-10 employees. Core technologies: Biologicals, Cells.
The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StageSeed
- ProductClinical Trial
- ModelB2B
- Employees1-10
- HQYavne
- DistrictCenter District
- Last RoundUndisclosed
- Peregrine Ventures
- NFX Capital
Anat BurkovitzCo-founder & CEO
Amir AharoniCo-Founder and R&D
Noam Diamant Co-founder & former BD
What does Trojan Bio do?
Trojan Bio is a preclinical immunotherapy company developing a novel class of therapeutic antibodies for the treatment of a variety of cancers. The company’s Trojan antibodies integrate viral peptides to efficiently activate the immune system for cancer eradication. Trojan Bio specific antibody is composed of 2 modules - Cancer targeting module and a Viral immunity activation module. It targets cancer cells and label them as virally infected cells. The company is harnessing the powerful anti-viral immunity to fight a variety of cancers.
Who founded Trojan Bio?
Trojan Bio was founded in 2021 by Anat Burkovitz (Co-founder & CEO), Amir Aharoni (Co-Founder and R&D), Noam Diamant (Co-founder & former BD).
What sector is Trojan Bio in?
Trojan Bio operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Cells. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is Trojan Bio located?
Trojan Bio is based in HaKishon St 18, Yavne, Israel, Center District.